Infertility Drugs Market - Size, Share, Outlook, and Opportunity Analysis, 2019 – 2026

1

• Coherent Market Insights
• Market Research and Business Consulting Services
• https//www.coherentmarketinsights.com
• COVID-19 Impact Tracker

2
INFERTILITY DRUGS MARKET ANALYSIS

• Infertility Drugs Market, By Drug Type
  (Clomiphene citrate, Sex hormones, Gonadotropins,
  Bromocriptine, Cabergoline, Imipramine,
  Letrozole, and Metformin), By Route of
  Administration (Oral, Intravenous, Subcutaneous,
  and Intramuscular), By Gender (Male and Female),
  By Distribution Channel (Hospital Pharmacies,
  Retail Pharmacies and Online Pharmacies) and By
  Region (North America, Latin America, Europe,
  Asia Pacific, Middle East, and Africa) - Size,
  Share, Outlook, and Opportunity Analysis, 2019
  2026

3
Market Outlook

• In order to treat infertility problems among the
  population there are many dugs present in the
  market such as Clomiphene (Clomid), Letrozole
  (Femara), Gonadotropins, etc. These drugs are
  used to trigger ovulation or to trigger hormones
  for proper functioning of ovaries. According to
  data published in 2018, in Shady Grove Fertility,
  Clomiphene is being prescribed by doctors for
  more than 50 years and still being extensively
  used to treat infertility cases in women. High
  blood sugar levels and Poly Cystic Ovarian
  Syndrome (PCOS) also interferes in sustaining
  pregnancy. To control the blood sugar and PCOS
  Metformin is highly prescribed drug. Metformin is
  sold under the brand name of Glucophage,
  Glumetza, Glucophage XR, and Fortamet.

4
Market Dynamics
Increasing prevalence of infertility in couples
is highly contributing to infertility drugs
market size. For instance, According to Centres
for Disease Control and Prevention (CDC) report
of 2018, about 6 of women aged 15 to 44 years in
the U.S. were unable to get pregnant after one
year of trying (infertility). Also, about 12 of
women aged 15 to 44 years in the U.S. have
difficulty getting pregnant or carrying a
pregnancy to term. Infertility also affects
rising number of men. According to the same
source, almost 9 of men aged 25 to 44 years in
the U.S. reported that they required medical help
for reproduction.
5
Key features of the study

• This report provides in-depth analysis of the
  infertility drugs market, market size (US Mn),
  and Compound Annual Growth Rate (CAGR ()) for
  the forecast period 2018 2026, considering
  2017, as the base year
• It elucidates potential revenue opportunity
  across different segments and explains attractive
  investment proposition matrix for this market
• This study also provides key insights about
  market drivers, restraints, opportunities, new
  product launches or approval, market trends,
  regional outlook, and competitive strategies
  adopted by leading players

6

• Request Sample Report
• Download PDF Brochure
• Request Customization
• Talk to Analyst
• BUY NOW
• For Your Reference https//www.coherentmarketinsi
  ghts.com/press-release/infertility-drugs-market-to
  -surpass-us-62-billion-by-2026-1413

7
About Us

• Coherent Market Insights is a global market
  intelligence and consulting organization focused
  on assisting our plethora of clients achieve
  transformational growth by helping them make
  critical business decisions.
• What we provide
• Customized Market Research Services
• Industry Analysis Services
• Business Consulting Services
• Market Intelligence Services
• Long term Engagement Model
• Country Specific Analysis

8
Contact Us

• Mr. Shah
• Coherent Market Insights Private Ltd.
• Address 1001 4th Ave, 3200 Seattle, WA 98154,
  U.S.
• Phone [phone]
• Email sales_at_coherentmarketinsights.com

9

• Thank You!
• Kindly follow CMI Social Media
• Profiles for the latest company updates
• Facebook LinkedIn
• Twitter
• https//www.coherentmarketinsights.com/